BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32053702)

  • 21. Management quality indicators and in-hospital mortality among acute coronary syndrome patients admitted to tertiary hospitals in Ethiopia: prospective observational study.
    Fanta K; Daba FB; Tegene E; Melaku T; Fekadu G; Chelkeba L
    BMC Emerg Med; 2021 Mar; 21(1):41. PubMed ID: 33789565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.
    Griffiths B; Lesosky M; Ntsekhe M
    S Afr Med J; 2014 Jun; 104(7):483-7. PubMed ID: 25214049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute coronary syndromes in patients with active hematologic malignancies - Incidence, management, and outcomes.
    Park JY; Guo W; Al-Hijji M; El Sabbagh A; Begna KH; Habermann TM; Witzig TE; Lewis BR; Lerman A; Herrmann J
    Int J Cardiol; 2019 Jan; 275():6-12. PubMed ID: 30318297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
    Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barón AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K
    Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
    Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
    J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex Differences in In-Hospital Management and Outcomes of Patients With Acute Coronary Syndrome.
    Hao Y; Liu J; Liu J; Yang N; Smith SC; Huo Y; Fonarow GC; Ge J; Taubert KA; Morgan L; Zhou M; Xing Y; Ma CS; Han Y; Zhao D
    Circulation; 2019 Apr; 139(15):1776-1785. PubMed ID: 30667281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term and long-term mortality associated with ventricular arrhythmia in patients hospitalized with acute coronary syndrome: findings from the Gulf RACE registry-2.
    Hersi A; Alhabib KF; Alsheikh-Ali AA; Sulaiman K; Alfaleh HF; Alsaif S; Al-Mahmeed W; Asaad N; Amin H; Al-Motarreb A; Al Suwaidi J
    Coron Artery Dis; 2013 Mar; 24(2):160-4. PubMed ID: 23363987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of in-hospital cardiac rehabilitation program on medication adherence and clinical outcomes in patients with acute myocardial infarction in the Lazio region of Italy.
    Soldati S; Di Martino M; Rosa AC; Fusco D; Davoli M; Mureddu GF
    BMC Cardiovasc Disord; 2021 Sep; 21(1):466. PubMed ID: 34565326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
    Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236
    [No Abstract]   [Full Text] [Related]  

  • 30. Mortality trends in women and men presenting with acute coronary syndrome: insights from a 20-year registry.
    El-Menyar A; Ahmed E; Albinali H; Al-Thani H; Gehani A; Singh R; Al Suwaidi J
    PLoS One; 2013; 8(7):e70066. PubMed ID: 23936143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
    Di Martino M; Alagna M; Lallo A; Gilmore KJ; Francesconi P; Profili F; Scondotto S; Fantaci G; Trifirò G; Isgrò V; Davoli M; Fusco D
    BMC Cardiovasc Disord; 2021 Apr; 21(1):180. PubMed ID: 33853534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of hospitalization period and five-year follow-up of patients admitted with acute coronary syndrome following coronary artery bypass graft surgery].
    Can LH; Kayıkçıoğlu M; Yavuzgil O; Kültürsay H; Soydan I
    Turk Kardiyol Dern Ars; 2010 Sep; 38(6):387-92. PubMed ID: 21200116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescribing Performance Post-Acute Coronary Syndrome Using a Composite Medication Indicator: ANZACS-QI 24.
    Kasargod C; Devlin G; Lee M; White HD; Kerr AJ
    Heart Lung Circ; 2020 Jun; 29(6):824-834. PubMed ID: 31255479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
    Looi KL; Chow KL; Looi JL; Lee M; Halliday S; White H; Ellis C
    N Z Med J; 2011 Sep; 124(1343):18-27. PubMed ID: 21964009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today?
    Raposeiras-Roubín S; Abu-Assi E; Redondo-Diéguez A; González-Ferreiro R; López-López A; Bouzas-Cruz N; Castiñeira-Busto M; Peña Gil C; García-Acuña JM; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):585-91. PubMed ID: 25511558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007.
    Ranasinghe I; Alprandi-Costa B; Chow V; Elliott JM; Waites J; Counsell JT; Lopéz-Sendón J; Avezum A; Goodman SG; Granger CB; Brieger D
    Am J Cardiol; 2011 Sep; 108(5):617-24. PubMed ID: 21714948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of adherence to composite therapy after acute coronary syndromes.
    Stabile E; Franzese M; Chianese S; Alfani A; Gerardi D; Colaiori I; Annunziata M; Nappi P; Scalise M; Di Serafino L; Puzone B; Avvedimento M; Leone A; Ilardi F; Piccolo R; Franzone A; Cirillo P; Morisco C; Trimarco B; Esposito G
    J Cardiovasc Med (Hagerstown); 2021 Aug; 22(8):645-651. PubMed ID: 33966020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and design.
    Flather MD; Booth J; Babalis D; Bueno H; Steg PG; Opolski G; Ottani F; Machecourt J; Bardaji A; Bojestig M; Brady AR; Lindahl B
    Trials; 2010 Jan; 11():5. PubMed ID: 20074348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.